146 related articles for article (PubMed ID: 20110536)
1. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in acute ischemic stroke.
Loh PK; Sharma VK
Stroke; 2010 Mar; 41(3):e164; author reply 165. PubMed ID: 20110536
[No Abstract] [Full Text] [Related]
2. Intravenous thrombolysis for ischemic stroke in recurrent oligodendroglioma: a case report.
Dafer RM; Paleologos N; Lynch D
J Stroke Cerebrovasc Dis; 2014; 23(5):1235-8. PubMed ID: 24103669
[TBL] [Abstract][Full Text] [Related]
3. Comment on "Efficacy and safety of different doses of intravenous tissue plasminogen activator in Chinese patients with ischemic stroke".
Ahmad A; Sharma VK
J Clin Neurosci; 2011 Jan; 18(1):160-1; author reply 161. PubMed ID: 20932764
[No Abstract] [Full Text] [Related]
4. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
5. Comparison of partial (.6 mg/kg) versus full-dose (.9 mg/kg) intravenous recombinant tissue plasminogen activator followed by endovascular treatment for acute ischemic stroke: a meta-analysis.
Georgiadis AL; Memon MZ; Shah QA; Vazquez G; Suri MF; Lakshminarayan K; Qureshi AI
J Neuroimaging; 2011 Apr; 21(2):113-20. PubMed ID: 19909396
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
[TBL] [Abstract][Full Text] [Related]
7. Administration of intravenous tissue plasminogen activator in a pediatric patient with acute ischemic stroke.
Shuayto MI; Lopez JI; Greiner F
J Child Neurol; 2006 Jul; 21(7):604-6. PubMed ID: 16970853
[TBL] [Abstract][Full Text] [Related]
8. Ischaemic stroke and thrombolysis: ask the onset time, not the age!
Cenciarelli S; Mazzoli T; Ricci S
Intern Emerg Med; 2013 Mar; 8(2):99-100. PubMed ID: 23184442
[No Abstract] [Full Text] [Related]
9. Correlation of Changes in Leukocytes Levels 24 Hours after Intravenous Thrombolysis With Prognosis in Patients With Acute Ischemic Stroke.
Chen J; Zhang Z; Chen L; Feng X; Hu W; Ge W; Li X; Jin P; Shao B
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2857-2862. PubMed ID: 30064868
[TBL] [Abstract][Full Text] [Related]
10. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?
Shaltoni HM; Albright KC; Gonzales NR; Weir RU; Khaja AM; Sugg RM; Campbell MS; Cacayorin ED; Grotta JC; Noser EA
Stroke; 2007 Jan; 38(1):80-4. PubMed ID: 17122433
[TBL] [Abstract][Full Text] [Related]
11. Low-dose versus standard-dose tissue plasminogen activator for intravenous thrombolysis in Asian acute ischemic stroke patients.
Ng KW; Sharma VK
Stroke; 2010 Aug; 41(8):e545-6; author reply e547-8. PubMed ID: 20595667
[No Abstract] [Full Text] [Related]
12. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke in a patient treated with rivaroxaban.
van Hooff RJ; Nieboer K; De Smedt A; Yperzeele L; Jochmans K; De Keyser J; Brouns R
Clin Neurol Neurosurg; 2014 Jul; 122():133-4. PubMed ID: 24813326
[No Abstract] [Full Text] [Related]
13. Combined intraarterial/intravenous thrombolysis for acute ischemic stroke.
Keris V; Rudnicka S; Vorona V; Enina G; Tilgale B; Fricbergs J
AJNR Am J Neuroradiol; 2001 Feb; 22(2):352-8. PubMed ID: 11156782
[TBL] [Abstract][Full Text] [Related]
14. Successful intravenous thrombolysis in ischemic stroke caused by infective endocarditis.
Junna M; Lin CC; Espinosa RE; Rabinstein AA
Neurocrit Care; 2007; 6(2):117-20. PubMed ID: 17522795
[TBL] [Abstract][Full Text] [Related]
15. Sonothrombolysis: An effective adjunct to intravenous tissue plasminogen activator therapy in acute ischemic stroke.
Miyachi S
Neurol India; 2017; 65(1):20-21. PubMed ID: 28084233
[No Abstract] [Full Text] [Related]
16. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study.
Sørensen SB; Barazangi N; Chen C; Wong C; Grosvenor D; Rose J; Bedenk A; Morrow M; McDermott D; Hove JD; Tong DC
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1110-1118. PubMed ID: 26897101
[TBL] [Abstract][Full Text] [Related]
17. Intravenous thrombolysis in patients older than age 80 years.
Longstreth WT; Tirschwell DL
Stroke; 2010 Oct; 41(10):e580; author reply e581. PubMed ID: 20798362
[No Abstract] [Full Text] [Related]
18. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K
Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a modified intravenous recombinant tissue plasminogen activator regimen in Chinese patients with acute ischemic stroke.
Pan SM; Liu JF; Liu M; Shen S; Li HJ; Dai LH; Chen XJ
J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):690-3. PubMed ID: 23111010
[TBL] [Abstract][Full Text] [Related]
20. Myocardial Infarction Following Intravenous Thrombolysis for Acute Ischemic Stroke: Case Report and Literature Review.
Mannino M; Asciutto S; Terruso V; Gammino M; Cellura MG; Monaco S
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):e105-e107. PubMed ID: 28434774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
